← feed

Is NCT02931214 results overdue?

Yes — results are overdue. Primary completion was 2017-10; the FDAAA-801 reporting deadline (2018-10-31) passed 2790 days ago and no results are posted on ClinicalTrials.gov.

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers

NCT IDNCT02931214 ↗
SponsorGlycoMimetics Incorporated (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-10 (ACTUAL)
Reporting deadline2018-10-31 (completion + 365d)
Days overdue2790
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 c7eec8b2544b4ea0… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02931214. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →